Medical Condition News

RSS

Focused ultrasound shows potential to benefit people with Parkinson's disease

A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, new research suggests.

7 Jan 2021

Researchers develop deep learning model to predict occult peritoneal metastasis in gastric cancer patients

Stomach cancer, or gastric cancer, is a common gastrointestinal malignancy. Peritoneal metastasis occurs in a majority of patients with advanced stomach cancer and is considered as an aggressive disease with poor outcomes.

7 Jan 2021

Common gene expression changes at target tissues of four autoimmune diseases found

Autoimmune diseases are diseases of "mistaken identity", where the immune system - which is supposed to protect us against infectious diseases and neoplasias - mistakenly attacks and destroys components of our own body.

7 Jan 2021

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown.

7 Jan 2021

Study highlights the benefits of HEMS interventions to improve triage for trauma patients

Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.

7 Jan 2021

New initiative to represent the Black community in mental healthcare

The Black Mind Initiative aims to reform the current mental health system nationally, by encouraging young Black people to take up a degree related to the mental health profession, the initiative will then support them in their studies and encourage them to work in senior roles in mental healthcare.

7 Jan 2021

Novel low molecular weight dextran-sulphate could play a key role in glaucoma treatment

Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB® could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over 70 million people worldwide and causes irreversible blindness.

7 Jan 2021

Mass spectrometry imaging shows promise in diagnosing brain diseases

Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations.

7 Jan 2021

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic research collaboration and commercialization agreement to develop novel CD3 bispecific antibody therapeutics for the potential treatment of patients with cancer.

7 Jan 2021

CytoDel successfully delivers neuronal antibody in animal models of botulism

CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the Company's lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. The complete text of the article titled, "Neuronal Delivery of Antibodies has Therapeutic Effects in Animal Models of Botulism," can be found here.

7 Jan 2021

New approach can help identify novel treatments for autoimmune diseases

A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, PhD, has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues.

7 Jan 2021

Repurposed drug can treat hearing loss in humans

According to the World Health Organization, around 466 million people worldwide have disabling hearing loss, a number the organization projects will double by 2050 to affect 1 in 10 people.

7 Jan 2021

Researchers examine effective treatments for victims struggling with chronic pain and PTSD

Post-traumatic stress disorder, or PTSD, affects many people who are exposed to extreme situations, such as torture. Recent research suggests that chronic pain may make it more difficult to treat trauma

7 Jan 2021

Understanding traumatic brain injury in women

Analysis from a workshop convened by the National Institute of Neurological Disorders and Stroke (NINDS) in 2017 reveals gaps in and opportunities for research to improve understanding of the effects of traumatic brain injury (TBI) in women.

7 Jan 2021

Patients with heart failure should take more precautions against COVID-19

Patients with acute heart failure nearly double their risk of dying if they get COVID-19, according to research published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).

7 Jan 2021

Study analyzes how artificial intelligence system helps diagnose adverse childhood experiences

A paper written by Arash Shaban-Nejad, PhD, MPH, an assistant professor, and Nariman Ammar, PhD, a postdoctoral fellow, both at the Center for Biomedical Informatics in the Department of Pediatrics at the University of Tennessee Health Science Center, was recently published in the Journal of Medical Internet Research - Medical Informatics.

7 Jan 2021

Opioid use may increase the risk of pancreatic cancer

Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.

6 Jan 2021

Study investigates control mechanism that ensures accurate chromosome inheritance during cell division

Starting as a single cell, organisms undergo millions of generations of divisions to ultimately generate the bones, heart, brain and other components that make up a living being.

6 Jan 2021

Main bioactive compound of ginger root may protect against autoimmune disease progression

Naturopathic medicine, or herbal medicine, is all the rage, especially among young people. But how much of this is supported by science?

6 Jan 2021

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that RHB-204 has been granted Fast Track designation by the U.S. Food and Drug Administration for its development as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) - a rare disease for which there is no FDA-approved first-line therapy.

6 Jan 2021

Medical Condition News

Focused ultrasound shows potential to benefit people with Parkinson's disease

Researchers develop deep learning model to predict occult peritoneal metastasis in gastric cancer patients

Common gene expression changes at target tissues of four autoimmune diseases found

Defective metabolism of Parkinson’s drug is linked to adverse side effects

Study highlights the benefits of HEMS interventions to improve triage for trauma patients

New initiative to represent the Black community in mental healthcare

Novel low molecular weight dextran-sulphate could play a key role in glaucoma treatment

Mass spectrometry imaging shows promise in diagnosing brain diseases

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

CytoDel successfully delivers neuronal antibody in animal models of botulism

New approach can help identify novel treatments for autoimmune diseases

Repurposed drug can treat hearing loss in humans

Researchers examine effective treatments for victims struggling with chronic pain and PTSD

Understanding traumatic brain injury in women

Patients with heart failure should take more precautions against COVID-19

Study analyzes how artificial intelligence system helps diagnose adverse childhood experiences

Opioid use may increase the risk of pancreatic cancer

Study investigates control mechanism that ensures accurate chromosome inheritance during cell division

Main bioactive compound of ginger root may protect against autoimmune disease progression

RedHill Biopharma: RHB-204 receives FDA Fast Track designation for treatment of NTM disease

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News